FDA Issues Final Guidance on Predetermined Change Control Plans for AI-Enabled Devices
By EsqSocial Corporation 23/12/24
On December 3, 2024, the US Food and Drug Administration (FDA) published final guidance titled, Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions....
By: McDermott+